|
π
|
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
17 auth.
J. Chataway,
N. Schuerer,
A. Alsanousi,
D. Chan,
D. MacManus,
K. Hunter,
V. Anderson,
Charles R. M. Bangham,
S. Clegg,
Casper Nielsen,
...
Nick C Fox,
D. Wilkie,
Jennifer M. Nicholas,
V. Calder,
J. Greenwood,
C. Frost,
R. Nicholas
|
8 |
2014 |
8
π
|
|
π
|
Automatic morphometry in Alzheimer's disease and mild cognitive impairment
8 auth.
R. Heckemann,
S. Keihaninejad,
P. Aljabar,
K. Gray,
Casper Nielsen,
D. Rueckert,
...
J. Hajnal,
A. Hammers
|
7 |
2011 |
7
π
|
|
π
|
Volume changes in Alzheimerβs disease and mild cognitive impairment: cognitive associations
12 auth.
Matthew C Evans,
J. Barnes,
Casper Nielsen,
L. Kim,
S. Clegg,
M. Blair,
...
K. Leung,
A. Douiri,
Richard Graham Boyes,
S. Ourselin,
Nick C Fox,
And the Alzheimerβs Disease Neuroimaging Initiative
|
6 |
2010 |
6
π
|
|
π
|
Comparison of phantom and registration scaling corrections using the ADNI cohort
11 auth.
M. Clarkson,
S. Ourselin,
Casper Nielsen,
K. Leung,
J. Barnes,
J. Whitwell,
...
J. Gunter,
D. Hill,
M. Weiner,
C. Jack,
Nick C Fox
|
5 |
2009 |
5
π
|
|
π
|
Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease.
15 auth.
G. Novak,
Nick C Fox,
S. Clegg,
Casper Nielsen,
S. Einstein,
Yuan Lu,
I. C. Tudor,
K. Gregg,
J. Di,
P. Collins,
...
B. Wyman,
E. Yuen,
M. Grundman,
H. Brashear,
E. Liu
|
5 |
2015 |
5
π
|
|
π
|
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial
46 auth.
P. Kehoe,
Nicholas L Turner,
B. Howden,
Lina JarutytΔ,
S. Clegg,
I. Malone,
J. Barnes,
Casper Nielsen,
C. Sudre,
Aileen Wilson,
N. J. Thai,
P. Blair,
E. Coulthard,
J. Lane,
P. Passmore,
...
Jodi Taylor,
HenkβJan Mutsaerts,
D. Thomas,
Nick C Fox,
Ian Wilkinson,
Y. Ben-Shlomo,
K. Harkness,
T. Kuruvilla,
R. McShane,
P. Connelly,
Gordon W. Duncan,
Lucy Calvert,
A. Lawrie,
M. Sheridan,
Eric Jackson,
B. Udeze,
S. Pearson,
T. Langheinrich,
Suvarna Wagle,
J. Butchart,
Ajay Macharouthu,
A. Donaldson,
W. Neil,
Vivek Pattan,
D. Findlay,
Alan J. Thomas,
Robert Barber,
A. Byrne,
Madhusudan ( Amod) Mangesh Dalvi,
R. Negi,
B. McGuinness
|
4 |
2021 |
4
π
|
|
π
|
Eff ect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis ( MS-STAT ) : a randomised , placebo-controlled , phase 2 trial
16 auth.
J. Chataway,
N. Schuerer,
A. Alsanousi,
D. Chan,
D. MacManus,
K. Hunter,
V. Anderson,
S. Clegg,
Casper Nielsen,
Nick C Fox,
...
D. Wilkie,
Jennifer M. Nicholas,
V. Calder,
J. Greenwood,
C. Frost,
R. Nicholas
|
3 |
2014 |
3
π
|
|
π
|
THE MS-STAT TRIAL: High Dose Simvastatin Slows Brain Atrophy and Delays Disability in Secondary Progressive Multiple Sclerosis: A Phase II Placebo-Controlled Trial (PL02.001)
18 auth.
J. Chataway,
N. Schuerer,
A. Alsanousi,
D. Chan,
D. MacManus,
K. Hunter,
V. Anderson,
J. Foster,
Charles R. M. Bangham,
S. Clegg,
...
Casper Nielsen,
Nick C Fox,
D. Wilkie,
Jennifer M. Nicholas,
V. Calder,
J. Greenwood,
C. Frost,
R. Nicholas
|
2 |
2013 |
2
π
|
|
π
|
Losartan to slow the progression of mild-to-moderate Alzheimerβs disease through angiotensin targeting: the RADAR RCT
21 auth.
P. Kehoe,
Nicholas L Turner,
B. Howden,
Lina Jarutyt,
S. Clegg,
I. Malone,
J. Barnes,
Casper Nielsen,
C. Sudre,
Aileen Wilson,
...
N. J. Thai,
P. Blair,
E. Coulthard,
J. Lane,
P. Passmore,
Jodi Taylor,
H. Mutsaerts,
D. Thomas,
Nick C Fox,
Ian Wilkinson,
Y. Ben-Shlomo
|
2 |
2021 |
2
π
|
